This inventor holds 2 USPTO granted patents. Top assignees: Assistance Publique-Hopitaux De Paris, National Institute of Health and Medical Research, Universite Paris Cité. Active years: 2022-2023.
Location History:
- France, FR (2022)
- Villejuif, FR (2023)
Company Filing History:
2 out of 331 
2 out of 1,853 
2 out of 72 
Years Active: 2022-2023
Title: **Inventor Profile: Ali Turhan**
Introduction
Ali Turhan is a notable inventor based in France, holding two patents focused on innovative cancer therapies. His work demonstrates a significant advancement in the treatment of cancers expressing embryonic antigens, showcasing his commitment to improving health outcomes through scientific research.
Latest Patents
Ali Turhan's latest patents revolve around methods and compositions for treating various cancers. One of his inventions introduces a novel therapeutic strategy involving the administration of engineered fetal stem cells that carry cancer-associated fetal neo-antigens. This method allows for a combination of treatments that can be administered simultaneously, separately, or sequentially, aiming for optimal effectiveness in cancer therapy.
In another significant patent, Turhan and his team developed a metastatic 4T1 breast tumor model using BALB/c mice. Their research uncovered that a vaccination combining xenogeneic embryonic stem cells with valproic acid (VPA) leads to a heightened anti-tumoral response against breast cancer and effectively inhibits the development of metastasis. This innovative approach highlights that therapeutic benefits arise from the inclusion of valproic acid in the treatment regimen, outperforming the use of embryonic stem cells or induced pluripotent stem cells alone.
Career Highlights
Throughout his career, Ali Turhan has contributed to prominent research institutions, including the Institut National de la Santé et de la Recherche Médicale and Assistance Publique - Hôpitaux de Paris. His affiliations with these esteemed organizations underline his participation in groundbreaking medical research and innovation.
Collaborations
Turhan has collaborated with esteemed coworkers such as Frank Griscelli and Annelise Bennaceur Griscelli, which has likely enhanced his research capabilities and broadened the impact of his inventions. These partnerships have contributed significantly to the developments in cancer treatment methodologies that Turhan is known for.
Conclusion
Ali Turhan's contributions to the field of cancer treatment through his innovative patents reflect his dedication and expertise as an inventor. His groundbreaking work paves the way for new therapeutic strategies that could significantly improve treatment outcomes for patients suffering from cancer. As his research continues to evolve, the medical field anticipates further advancements resulting from his ongoing efforts.